Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress with peptide scanning to study structure-activity relationships: the implications for drug discovery
Stéphanie Eustache, Jérôme Leprince, Pierre Tufféry
Expert Opinion on Drug Discovery (2016) Vol. 11, Iss. 8, pp. 771-784
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Therapeutic peptides: current applications and future directions
Lei Wang, Nanxi Wang, Wenping Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1163
The Current State of Peptide Drug Discovery: Back to the Future?
Antoine Henninot, James C. Collins, John M. Nuss
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 4, pp. 1382-1414
Closed Access | Times Cited: 945
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
Andy Chi-Lung Lee, Janelle L. Harris, Kum Kum Khanna, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2383-2383
Open Access | Times Cited: 599
Peptide Design Principles for Antimicrobial Applications
Marcelo D. T. Torres, Shanmugapriya Sothiselvam, Timothy K. Lu, et al.
Journal of Molecular Biology (2019) Vol. 431, Iss. 18, pp. 3547-3567
Open Access | Times Cited: 374
Interfering peptides targeting protein–protein interactions: the next generation of drugs?
Heriberto Bruzzoni‐Giovanelli, Valérie Alezra, Nicolas Wolff, et al.
Drug Discovery Today (2017) Vol. 23, Iss. 2, pp. 272-285
Closed Access | Times Cited: 128
Antimicrobial Peptides and Their Mimetics: Promising Candidates of Next‐Generation Therapeutic Agents Combating Multidrug‐Resistant Bacteria
Tianyi Zhang, Qiao Jin, Jian Ji
Advanced Biology (2025)
Closed Access | Times Cited: 1
Endozepines and their receptors: Structure, functions and pathophysiological significance
Marie‐Christine Tonon, Hubert Vaudry, Julien Chuquet, et al.
Pharmacology & Therapeutics (2019) Vol. 208, pp. 107386-107386
Open Access | Times Cited: 63
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
Isabelle Aillaud, Susanne Aileen Funke
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 3, pp. 951-961
Open Access | Times Cited: 32
The Arg–Phe‐amide peptide 26RFa/glutamine RF‐amide peptide and its receptor: IUPHAR Review 24
Jérôme Leprince, Didier Bagnol, Ronan Bureau, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 20, pp. 3573-3607
Open Access | Times Cited: 46
Main methods and tools for peptide development based on protein-protein interactions (PPIs).
Javiera Baeza, Mauricio Bedoya, Pablo Cruz, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151623-151623
Closed Access
Harnessing marine antimicrobial peptides for novel therapeutics: A deep dive into ocean-derived bioactives
Kunal Agam Kanaujia, Suraj Wagh, Giriraj Pandey, et al.
International Journal of Biological Macromolecules (2025) Vol. 307, pp. 142158-142158
Closed Access
Mirror‐Image Phage Display for the Selection of D‐Amino Acid Peptide Ligands as Potential Therapeutics
Marwa Malhis, Susanne Aileen Funke
Current Protocols (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 3
P17 induces chemotaxis and differentiation of monocytes via MRGPRX2-mediated mast cell–line activation
Karthi Duraisamy, Kailash Singh, Mukesh Kumar, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 1, pp. 275-291
Open Access | Times Cited: 22
Total Synthesis and Structure–Activity Relationships Study of Odilorhabdins, a New Class of Peptides Showing Potent Antibacterial Activity
Matthieu Sarciaux, Lucile Pantel, Camille Midrier, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 17, pp. 7814-7826
Closed Access | Times Cited: 27
Importance of Terminal Amino Acid Residues to the Transport of Oligopeptides across the Caco-2 Cell Monolayer
Long Ding, Liying Wang, Zhipeng Yu, et al.
Journal of Agricultural and Food Chemistry (2017) Vol. 65, Iss. 35, pp. 7705-7712
Closed Access | Times Cited: 24
Alanine-Scanning Mutagenesis of α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor
Jiong Ning, Rui Li, Jie Ren, et al.
Marine Drugs (2018) Vol. 16, Iss. 12, pp. 507-507
Open Access | Times Cited: 20
A Review on Azapeptides: The Promising Peptidomimetics
Arifa Begum, Sujatha Dodoala, K. V. S. R. G. Prasad, et al.
Asian Journal of Chemistry (2017) Vol. 29, Iss. 9, pp. 1879-1887
Open Access | Times Cited: 19
Exhaustive Exploration of the Conformational Landscape of Small Cyclic Peptides Using a Robotics Approach
Maud Jusot, Dirk Stratmann, Marc Vaisset, et al.
Journal of Chemical Information and Modeling (2018) Vol. 58, Iss. 11, pp. 2355-2368
Open Access | Times Cited: 15
PEG-BHD1028 Peptide Regulates Insulin Resistance and Fatty Acid β-Oxidation, and Mitochondrial Biogenesis by Binding to Two Heterogeneous Binding Sites of Adiponectin Receptors, AdipoR1 and AdipoR2
In Kyung Lee, Gyuyoup Kim, Do‐Hwi Kim, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 884-884
Open Access | Times Cited: 12
Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro
Dan Wang, Cheng Lu, Jieru Li, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 167, pp. 106009-106009
Closed Access | Times Cited: 12
Influence of Aza-Glycine Substitution on the Internalization of Penetratin
Karima Tarchoun, Dóra Soltész, Viktor Farkas, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 477-477
Open Access | Times Cited: 1
Identification of Crucial Residues in α-Conotoxin EI Inhibiting Muscle Nicotinic Acetylcholine Receptor
Jiong Ning, Jie Ren, Yang Xiong, et al.
Toxins (2019) Vol. 11, Iss. 10, pp. 603-603
Open Access | Times Cited: 8
Targeting Protein Interaction Hotspots Using Structured and Disordered Chimeric Peptide Inhibitors
Guy Mayer, Zohar Shpilt, Hadar Kowalski, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 7, pp. 1811-1823
Closed Access | Times Cited: 4
Integrating deep mutational scanning and low-throughput mutagenesis data to predict the impact of amino acid variants
Yunfan Fu, Justin Bedő, Anthony T. Papenfuss, et al.
GigaScience (2022) Vol. 12
Open Access | Times Cited: 4
Steric impact of aza-amino acid on solid-phase aza-peptide bond synthesis
Alla Troska, Meeli Arujõe, Anton Mastitski, et al.
Tetrahedron Letters (2021) Vol. 69, pp. 152973-152973
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top